RxDoctor Payments Data

Daniel Weikert, MD

Ophthalmology · Franklin, TNNPI 1902838550

Payments from drug & device makers

$2,707in general payments, 2019–2025

Across 53 payments — averaging $51.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • AbbVie$591
  • Mindray DS USA, Inc.$47
  • Alcon Research LLC$37
  • Mallinckrodt Hospital Products Inc.$29
  • Mallinckrodt Enterprises LLC$23
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$2,707100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,707 in reported general payments places this provider in the 60th percentile of 323 ophthalmology providers in Tennessee.

See all ophthalmology providers in Tennessee

Medicare billing

Part B allowed, 2024
$394,864
Medicare patients
1,250
Services billed
2,795

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost28$17,558
Latanoprost480$7,245
Travoprost28$6,088
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol32$5,344
CombiganBrimonidine Tartrate/Timolol13$4,604
RocklatanNetarsudil Mesylat/Latanoprost12$4,168
Prednisolone Acetate91$3,596
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat154$2,918
Timolol Maleate146$2,165
Fluorometholone25$2,003
Brimonidine Tartrate84$1,368
Dorzolamide Hcl48$686
MoxifloxacinMoxifloxacin Hcl12$414
Ketorolac Tromethamine11$274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Combigan$591$22,16241 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 323 ophthalmology providers in Tennessee.

Other ophthalmology in Franklin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →